RHEACELL announces FDA approval for Phase 3 study in refractory, non-curable CVU
more
Stories about Genetik
New Study: Father's Diet Before Conception Influences Children's Health
moreAdvanced Brain Science Without Coding Expertise
moreScientists Reveal Adipocyte's Metabolic Role and Identify Treatment Targets
more- 4
FDX Fluid Dynamix and Fraunhofer IPK to Collaborate with Lonza on Novel Nanoparticle Formulation Technology Platform FDmiX
more Research Success in Rare Disease / RHEACELL receives positive signal for accelerated stem cell development program in rare ‚Butterfly Disease‘
moreRising Focus on 'Inceptor' as a Type 2 Diabetes Therapeutic Target
moreWhat Our Genetic Information Tells Us About Type 2 Diabetes Risk and Complications
moreStrengthening the Direct Sales and Service System for Business Expansion in Italy
One documentmoreBiomay Announces its Successful Support of Approval of First CRISPR/Cas9-based Therapy
moreCells of the Future: A Key To Reprogramming Cell Identities
moreNew Source of Stem Cells in Injury-Affected Brains of Patients
moreFraunhofer-Institut für Produktionstechnologie IPT
Pooling expertise: Fraunhofer IPT and Harro Höfliger cooperate in the manufacturing of ATMP production systems
moreBiomay Announces Expansion of GMP-Facilities to Offer mRNA Manufacturing and Aseptic Filling Services
moreA New Ally in Fighting Brain Diseases: Our Very Own Skull
moreWildDISCO: Visualizing Whole Bodies in Unprecedented Detail
morePotentiating Cancer Vulnerability to Ferroptosis: Off-Targeting Effects of DHODH Inhibitors
more- 2
CARAMBA: New Hope for Multiple Myeloma Patients
more New Approach in Cancer Therapy With Innovative Mechanism-of-Action for Ferroptosis Induction
moreRHEACELL announces “First Patient In”: EB-Haus in Salzburg, Austria starts pivotal study for stem cell therapy for severe forms of Epidermolysis bullosa that is longed for by those affected
moreArtilysin® - A Groundbreaking "Green Pharma" Solution
more- 2
Study Reveals Influence of Urban Environment on Mental Health
more Amicogen and Lysando: Novel approach for the treatment of mastitis in dairy cows
more- 3
Sysmex Europe distributes MammaTyper®, an advanced breast cancer diagnostic assay, through the European distribution agreement with Cerca Biotech
more EBiSC presents a new offering of iPSC-derived neurons
moreType 1 Diabetes Awareness Campaign - K1DS ARE HEROES - started
moreFlu tests from R-Biopharm also detect new virus variants
moreStem cell therapy for “Butterfly disease” / RHEACELL receives ‘Partners in Progress Award’ from debra of America for Epidermolysis Bullosa research
moreVectorBuilder Raised $57 Million for Gene Delivery R&D
moreVectorBuilder raised $57 million for gene delivery R&D
more
123Next